Kusatsu, Japan

Masaki Terada

This inventor holds 3 USPTO granted patents. Top assignees: Nissin Food Products Co., Ltd., Nissan Food Products Co., Ltd.. Active years: 2002-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaki Terada. Retrieved from https://idiyas.com/inventor/masaki-terada-pra9chom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2002-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masaki Terada: Innovator in Antiviral Compounds

Introduction

Masaki Terada is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of antiviral compounds, holding a total of 3 patents. His work focuses on developing compounds that exhibit antiviral activity while minimizing adverse effects.

Latest Patents

Among his latest patents, Terada has developed compounds that provide anti-retrovirus activity with low anti-coagulant action and low cytotoxicity. These compounds comprise glycosides or their salts, where a lipid is linked to position 2 of sialic acid, which has all hydroxyl groups at positions 4, 7, 8, and 9 completely sulfated. Additionally, he has worked on KDN (2-keto-3-deoxy-D-glycero-2-nononic acid) with similar sulfation characteristics.

Career Highlights

Throughout his career, Masaki Terada has been associated with prominent companies such as Nissin Food Products Co., Ltd. and Nissan Food Products Co., Ltd. His work in these organizations has contributed to advancements in food technology and antiviral research.

Collaborations

Terada has collaborated with notable colleagues, including Shuji Fujita and Masaaki Numata. These partnerships have fostered innovation and development in his field of expertise.

Conclusion

Masaki Terada's contributions to antiviral compounds highlight his dedication to scientific advancement. His innovative work continues to impact the field positively, showcasing the importance of research in developing effective antiviral solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…